MTVA net incomeQ2 2026-$5.32M
MTVA net income was -$5.32M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$4.00M a year earlier. For the full fiscal 2025 it was -$12.97M, compared with -$27.59M in fiscal 2024.
For the twelve months ended Jun 30, 2026, MetaVia Inc. reported -$14.45M of net income.
MTVA net income was -$5.32M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$4.00M a year earlier. For the full fiscal 2025 it was -$12.97M, compared with -$27.59M in fiscal 2024.
MTVA diluted EPS was -$0.90 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$7.35.
MTVA free cash flow was -$4.86M in fiscal Q4 2025 (ended Dec 31, 2025), compared with -$5.47M a year earlier. For the full fiscal 2025 it was -$15.70M, compared with -$24.72M in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $6.80M | $21.55M | $9.16M | $2.78M | $6.55M | $4.53M | $5.32M | $5.07M | $22.69M | $8.74M |
| Selling, general and admin | $6.91M | $7.26M | $6.73M | $8.64M | $8.75M | $7.85M | $2.70M | $1.60M | $10.44M | $5.96M |
| Operating income | -$13.71M | -$28.81M | -$15.89M | -$19.63M | -$15.30M | -$29.72M | -$20.18M | -$15.49M | -$33.12M | -$14.70M |
| Pre-tax income | -$12.97M | -$27.59M | -$12.47M | -$13.97M | -$15.28M | -$29.68M | -$21.31M | -$15.53M | -$33.41M | -$14.59M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$12.97M | -$27.59M | -$12.47M | -$13.97M | -$15.28M | -$29.68M | -$21.31M | -$15.53M | -$33.41M | -$14.59M |
| EPS, basic | -$7.35 | -$39.13 | -$27.06 | -$477.62 | -$1743.28 | -$4831.20 | -$10771.20 | -$9636.00 | -$8527.20 | -$6784.80 |
| EPS, diluted | -$7.35 | -$39.13 | -$27.06 | -$477.62 | -$1743.28 | -$4831.20 | -$10771.20 | -$9636.00 | -$8527.20 | -$6784.80 |
| Diluted shares | 1.8M | 705,193 | 461,009.182 | 29,245.727 | 8,766.159 | 6,142.931 | 1,978.855 | 1,610.352 | 3,920.127 | 2,200.529 |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $10.28M | $16.02M | $22.43M | $33.36M | $16.39M | $10.09M | $13.92M | $2.85M | $50.0K | $24.03M |
| Current assets | $10.88M | $16.07M | $22.51M | $33.53M | $16.58M | $10.68M | $14.12M | $3.81M | $19.01M | $24.75M |
| Total assets | $11.12M | $16.26M | $22.78M | $33.53M | $16.80M | $10.97M | $14.47M | $3.82M | $19.02M | $24.75M |
| Current liabilities | $5.65M | $8.27M | $5.96M | $11.78M | $2.16M | $3.69M | $2.08M | $219.0K | $6.39M | $4.12M |
| Long-term debt | - | - | - | - | - | - | - | $118.0K | - | - |
| Total debt | - | - | - | - | - | - | - | $118.0K | - | - |
| Total liabilities | $5.79M | $8.33M | $6.10M | $11.78M | $2.20M | $3.77M | $2.18M | $360.0K | $15.08M | $4.12M |
| Shareholders' equity | $5.33M | $7.93M | $16.68M | $21.75M | $14.60M | $7.20M | $12.29M | -$13.29M | $25.0K | $20.63M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$15.70M | -$24.71M | -$10.80M | -$11.71M | -$15.13M | -$10.76M | -$7.04M | -$14.45M | -$26.90M | -$11.04M |
| Capital expenditures | $2.0K | $8.0K | $50.0K | - | $3.0K | $4.0K | $214.0K | $3.0K | - | - |
| Free cash flow | -$15.70M | -$24.72M | -$10.85M | - | -$15.14M | -$10.77M | -$7.25M | -$14.45M | - | - |
| Investing cash flow | -$2.0K | -$8.0K | -$50.0K | $8.0K | -$586.0K | $69.0K | -$6.06M | -$3.0K | - | - |
| Financing cash flow | $9.96M | $18.30M | -$80.0K | $28.68M | $22.03M | $6.86M | $24.17M | $17.25M | $21.34M | $31.46M |
| Stock-based compensation | $411.0K | $538.0K | $222.0K | $854.0K | $662.0K | $699.0K | $118.0K | $4.13M | $5.27M | $1.72M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | -243.3% | -347.9% | -74.7% | -64.2% | -104.7% | -412.0% | -173.4% | - | -133660.0% | -70.7% |
| Return on assets | -116.6% | -169.7% | -54.7% | -41.7% | -91.0% | -270.6% | -147.3% | -406.5% | -175.7% | -58.9% |
| Current ratio | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | 17.39 | 2.97 | 6.00 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $3.48M | $2.10M | $241.0K | $1.91M | $2.32M | $2.33M | $4.06M | $4.52M | $8.07M | $4.90M | $3.87M | $2.29M |
| Selling, general and admin | $1.91M | $1.92M | $1.80M | $1.56M | $1.98M | $1.56M | $1.53M | $1.74M | $2.01M | $1.98M | $1.80M | $1.60M |
| Operating income | -$5.38M | -$4.03M | -$2.05M | -$3.48M | -$4.30M | -$3.89M | -$5.58M | -$6.26M | -$10.08M | -$6.88M | -$5.67M | -$3.89M |
| Pre-tax income | -$5.32M | -$3.82M | -$1.93M | -$3.38M | -$4.00M | -$3.67M | -$5.17M | -$5.65M | -$10.05M | -$6.71M | -$5.31M | -$3.82M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$5.32M | -$3.82M | -$1.93M | -$3.38M | -$4.00M | -$3.67M | -$5.17M | -$5.65M | -$10.05M | -$6.71M | -$5.31M | -$3.82M |
| EPS, basic | -$0.90 | -$0.79 | - | -$1.54 | -$2.87 | -$3.93 | - | -$6.05 | -$20.35 | -$14.52 | -$11.55 | -$8.25 |
| EPS, diluted | -$0.90 | -$0.79 | - | -$1.54 | -$2.87 | -$3.93 | - | -$6.05 | -$20.35 | -$14.52 | -$11.55 | -$8.25 |
| Diluted shares | 5.9M | 4.9M | - | 2.2M | 1.4M | 933,109 | - | 928,553.364 | 493,536.909 | 462,673.455 | - | 461,437.909 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $12.63M | $13.73M | $10.28M | $14.28M | $17.59M | $11.19M | $16.02M | $21.67M | $27.93M | $15.99M | $22.43M | $25.84M |
| Current assets | $13.07M | $14.16M | $10.88M | $14.65M | $18.32M | $11.96M | $16.07M | $21.93M | $28.52M | $16.76M | $22.51M | $26.14M |
| Total assets | $13.27M | $14.39M | $11.12M | $14.77M | $18.46M | $12.13M | $16.26M | $22.15M | $28.75M | $17.02M | $22.78M | $26.43M |
| Current liabilities | $6.35M | $5.19M | $5.65M | $8.43M | $8.82M | $7.71M | $8.27M | $9.11M | $9.71M | $6.83M | $5.96M | $4.72M |
| Total liabilities | $6.45M | $5.32M | $5.79M | $8.43M | $8.84M | $7.75M | $8.33M | $9.19M | $9.81M | $6.94M | $6.10M | $4.88M |
| Shareholders' equity | $6.82M | $9.07M | $5.33M | $6.33M | $9.62M | $4.38M | $7.93M | $12.95M | $18.94M | $10.08M | $16.68M | $21.55M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.76M | -$4.26M | -$4.86M | -$2.96M | -$3.07M | -$4.82M | -$5.47M | -$5.55M | -$7.25M | -$6.44M | -$3.39M | -$2.81M |
| Capital expenditures | - | - | $0 | $0 | - | - | $0 | $0 | $3.0K | $5.0K | $9.0K | $37.0K |
| Free cash flow | - | - | -$4.86M | -$2.96M | - | - | -$5.47M | -$5.55M | -$7.25M | -$6.45M | -$3.40M | -$2.85M |
| Investing cash flow | - | - | $0 | $0 | - | - | $0 | $0 | -$3.0K | -$5.0K | -$9.0K | -$37.0K |
| Financing cash flow | $2.67M | $7.71M | $861.0K | -$357.0K | $9.47M | -$12.0K | -$183.0K | -$717.0K | - | - | $0 | $0 |
| Stock-based compensation | $130.0K | $100.0K | $71.0K | $97.0K | $111.0K | $132.0K | $160.0K | $139.0K | $134.0K | $105.0K | $100.0K | $172.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 2.06 | 2.73 | 1.93 | 1.74 | 2.08 | 1.55 | 1.94 | 2.41 | 2.94 | 2.46 | 3.78 | 5.54 |
Source: XBRL data MetaVia Inc. files with the SEC, latest filing dated Aug 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-30, first reported Nov 14, 2022; 1-for-8, first reported Mar 28, 2024; 1-for-11, first reported Mar 26, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MTVA | - | - | -$14.45M | - | $9.8M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.35T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $675.92B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $519.48B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $364.98B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $311.52B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $289.61B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.31B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $180.22B |